Abbott Laboratories (ABT) Interest Expenses (2009 - 2026)

Abbott Laboratories (ABT) has 18 years of Interest Expenses data on file, last reported at $1.5 billion in Q1 2026.

• For the quarter ending Q1 2026, Interest Expenses rose 44.93% year-over-year to $1.5 billion; the trailing twelve-month figure through Mar 2026 stood at $1.5 billion (up 44.93% YoY), and the FY2025 full-year result was $9.7 billion, up 484.74% from the prior year.
• Interest Expenses climbed to $1.5 billion in Q1 2026, from $120.0 million in the prior quarter.
• In the past five years, Interest Expenses ranged from a high of $1.6 billion in Q1 2022 to a low of $120.0 million in Q4 2025.
• A 5-year average of $974.6 million and a median of $1.0 billion in 2025 frame the typical range for Interest Expenses.
• Across the five-year window, Interest Expenses surged 238.26% in 2022 and tumbled 37.31% in 2024, its largest moves.
• Tracing ABT's Interest Expenses over 5 years: stood at $159.0 million in 2022, then changed by 0.0% to $159.0 million in 2023, then fell by 14.47% to $136.0 million in 2024, then retreated by 11.76% to $120.0 million in 2025, then soared by 1150.0% to $1.5 billion in 2026.
• Business Quant data shows ABT's Interest Expenses at $1.5 billion in Q1 2026, $120.0 million in Q4 2025, and $995.0 million in Q3 2025.